[1] NIOSH. Preventing occupational exposures to antineoplastic and other hazardous drugs in health care settings[EB/OL]. 2004-09[2009- 10-15].http://www.exposurecontrol.nl/ publications/NIOSH2004. [2] Donner A L. Possible risk of working with antineoplestic drugs in horizontal laminar flow hoods [J].Am J Hosp Pharm,1978,35(8):900. [3] Sessink P J, Boer KA, Scheefhals AP, et al. Occupational exposure to antineplastic agents at several departments in a hospital. Environmental contamination and excretion of cyclophosphamide and ifosfamide in urine of exposed workers[J]. Int Arch Occup Environ Health, 1992,64(2):105-112. [4] Kromhout H, Hoek F, Uitterhoeve R, et al. Postulating a dermal pathway for exposure to anti-neoplastic drugs among hospital workers. Applying a conceptual model to the results of three workplace surveys[J]. Ann Occup Hyg, 2000,44(7):551-560. [5] 李茂莲,张月英,王清馨,等.职业接触抗肿瘤药物对护士外周血T淋巴细胞亚群的影响[J].中华劳动卫生职业病杂志,2005, 23(6):450-451. [6] 李茂莲,张月英,王清馨,等.职业接触抗肿瘤药物对护士血清免疫球蛋白的变化[J]. 护理研究,2004,18(5):909-910. [7] Sessink P J, Kroese E D, van Kranen H J, et al. Cancer risk assessment for health care workers occuoationally exposed to cyclop- hosphamide[J]. Int Arch Occup Environ Health, 1995,67(5):317-323. [8] Stucker I, Caillard J F, Collin R, et al. Risk of spontaneous abortion among nurses handing antineoplastic drugs[J]. Scand J Work Environ Health, 1990,16(2):102-107. [9] 谢金辉,王建,李海燕,等. 职业性接触抗癌药物对护士的生殖结局影响的流行病学研究[J].中华劳动卫生职业病杂志,2001,19(2):87-90. [10] OSHA.Work-practice guidelines for personnel dealing with cytotoxic(antineoplastic)drugs[J]. American Joumal of Hospital Pharmacy,1986,5(43):1183-1204. [11] 杨慧云,张华华,张瑞丽,等. 医院接触抗肿瘤药物人员健康状况调查分析[J]. 护理学杂志,2002,17(6):454-455. [12] 刘薇,周荣慧. 静脉药物配置中心的 特点与管理[J]. 护理管理杂志,2003,3(2):43-44. |